Cargando…
Moyamoya syndrome and neurofibromatosis type 1
Neurofibromatosis type 1 (NF1) is the most prevalent autosomal dominant genetic disorder among humans. NF1 vasculopathy is a significant but underrecognized complication of the disease, affecting both arterial and venous blood vessels of all sizes. Moyamoya syndrome is a cerebral vasculopathy that i...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104827/ https://www.ncbi.nlm.nih.gov/pubmed/24952383 http://dx.doi.org/10.1186/1824-7288-40-59 |
_version_ | 1782327291993391104 |
---|---|
author | Vargiami, Euthymia Sapountzi, Evdoxia Samakovitis, Dimitris Batzios, Spyros Kyriazi, Maria Anastasiou, Athanasia Zafeiriou, Dimitrios I |
author_facet | Vargiami, Euthymia Sapountzi, Evdoxia Samakovitis, Dimitris Batzios, Spyros Kyriazi, Maria Anastasiou, Athanasia Zafeiriou, Dimitrios I |
author_sort | Vargiami, Euthymia |
collection | PubMed |
description | Neurofibromatosis type 1 (NF1) is the most prevalent autosomal dominant genetic disorder among humans. NF1 vasculopathy is a significant but underrecognized complication of the disease, affecting both arterial and venous blood vessels of all sizes. Moyamoya syndrome is a cerebral vasculopathy that is only rarely observed in association with NF1, particularly in the pediatric age range. Herein, we report of a 5-year-old female with NF1 and moyamoya syndrome and we briefly review the existing literature. |
format | Online Article Text |
id | pubmed-4104827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41048272014-07-22 Moyamoya syndrome and neurofibromatosis type 1 Vargiami, Euthymia Sapountzi, Evdoxia Samakovitis, Dimitris Batzios, Spyros Kyriazi, Maria Anastasiou, Athanasia Zafeiriou, Dimitrios I Ital J Pediatr Case Report Neurofibromatosis type 1 (NF1) is the most prevalent autosomal dominant genetic disorder among humans. NF1 vasculopathy is a significant but underrecognized complication of the disease, affecting both arterial and venous blood vessels of all sizes. Moyamoya syndrome is a cerebral vasculopathy that is only rarely observed in association with NF1, particularly in the pediatric age range. Herein, we report of a 5-year-old female with NF1 and moyamoya syndrome and we briefly review the existing literature. BioMed Central 2014-06-21 /pmc/articles/PMC4104827/ /pubmed/24952383 http://dx.doi.org/10.1186/1824-7288-40-59 Text en Copyright © 2014 Vargiami et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Vargiami, Euthymia Sapountzi, Evdoxia Samakovitis, Dimitris Batzios, Spyros Kyriazi, Maria Anastasiou, Athanasia Zafeiriou, Dimitrios I Moyamoya syndrome and neurofibromatosis type 1 |
title | Moyamoya syndrome and neurofibromatosis type 1 |
title_full | Moyamoya syndrome and neurofibromatosis type 1 |
title_fullStr | Moyamoya syndrome and neurofibromatosis type 1 |
title_full_unstemmed | Moyamoya syndrome and neurofibromatosis type 1 |
title_short | Moyamoya syndrome and neurofibromatosis type 1 |
title_sort | moyamoya syndrome and neurofibromatosis type 1 |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104827/ https://www.ncbi.nlm.nih.gov/pubmed/24952383 http://dx.doi.org/10.1186/1824-7288-40-59 |
work_keys_str_mv | AT vargiamieuthymia moyamoyasyndromeandneurofibromatosistype1 AT sapountzievdoxia moyamoyasyndromeandneurofibromatosistype1 AT samakovitisdimitris moyamoyasyndromeandneurofibromatosistype1 AT batziosspyros moyamoyasyndromeandneurofibromatosistype1 AT kyriazimaria moyamoyasyndromeandneurofibromatosistype1 AT anastasiouathanasia moyamoyasyndromeandneurofibromatosistype1 AT zafeirioudimitriosi moyamoyasyndromeandneurofibromatosistype1 |